Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Jamie Heise"'
Autor:
Kimberly Farrand, J Brian Copley, Jamie Heise, Moshe Fridman, Michael Keith, Arthur Silverberg
Publikováno v:
Kidney Research and Clinical Practice, Vol 31, Iss 2, p A92 (2012)
Hyperphosphataemia is associated with increased all-cause mortality in patients with chronic kidney disease (CKD), but serum phosphate (P) levels can be managed by dialysis, diet and the use of P binders. Serum P data were obtained retrospectively fr
Externí odkaz:
https://doaj.org/article/e21dcfca406a4b9d8a6fb83a55eb5ed7
Autor:
J Brian Copley, Jamie Heise
Publikováno v:
Kidney Research and Clinical Practice, Vol 31, Iss 2, p A92 (2012)
Patients with chronic kidney disease undergoing haemodialysis have a maximum recommended dietary phosphate (P) intake of 1000 mg/day and a recommended protein intake of 1.2 g/kg/day. Achieving this level of protein intake is associated with the best
Externí odkaz:
https://doaj.org/article/26dff9d10a2843afbf4cf145e4bd614f
Autor:
Jamie Heise, Mitchell L. Shiffman, Deanine G. Halliman, Andrew J. Muir, Bruce R. Bacon, Eric Chun, Eric Lawitz, Janet Hammond, Tarek Hassanein, Fred Poordad
Publikováno v:
Hepatology (Baltimore, Md.). 52(4)
Ribavirin-induced hemolytic anemia can prompt dose reductions and lower sustained virologic response (SVR) rates in the treatment of patients with chronic hepatitis C. The study aimed to determine if weight-based dosing of taribavirin (TBV), an oral
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d9d1edcac727ea7a8a0858e487d720bf
https://pubmed.ncbi.nlm.nih.gov/20879028
https://pubmed.ncbi.nlm.nih.gov/20879028
Autor:
Jamie Heise, Mitchell L. Shiffman, Eric Chun, Nezam H. Afdhal, Yves Benhamou, David R. Nelson, Deanine G. Halliman, Paul J. Pockros
Publikováno v:
Hepatology (Baltimore, Md.). 50(3)
Pegylated interferon (peg-IFN) and ribavirin (RBV) are effective in eradicating the hepatitis C virus in more than half of patients. However, anemia arising from RBV-induced hemolysis can prompt dose reductions and lower sustained virologic response
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ac19e083f0a3fdc8c3025f4cc6de8859
https://pubmed.ncbi.nlm.nih.gov/19585653
https://pubmed.ncbi.nlm.nih.gov/19585653
Autor:
Deanine G. Halliman, Patrick Marcellin, Jamie Heise, Eric Chun, Robert G. Gish, Norman Gitlin, Maribel Rodriguez-Torres
Publikováno v:
Journal of hepatology. 52(1)
Pegylated interferon (peg-IFN) plus ribavirin (standard of care for chronic hepatitis C virus [HCV]), can cause dose-limiting anemia in up to 22% of patients. Viramidine is associated with a lower incidence of anemia because of its liver-targeting pr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9e209a4eeac12357562eb35e45323be4
https://pubmed.ncbi.nlm.nih.gov/19913323
https://pubmed.ncbi.nlm.nih.gov/19913323
Autor:
Fernando Gibson, Kimberly Farrand, J. Brian Copley, Jamie Heise, Moshe Fridman, Michael Keith, Lynne Poole
Publikováno v:
International Journal of Nephrology and Renovascular Disease
Kimberly F Farrand,1 J Brian Copley,1 Jamie Heise,1 Moshe Fridman,2 Michael S Keith,1 Lynne Poole3 1Shire, Wayne, PA, USA; 2AMF Consulting, Los Angeles, CA, USA; 3Shire, Basingstoke, UK Abstract: The purpose of this study was to conduct a retrospecti
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::04ded47d829e22dd11c4c1b894be4317
https://doi.org/10.2147/ijnrd.s58037
https://doi.org/10.2147/ijnrd.s58037
Autor:
Bruce R. Bacon, E.J. Lawitz, Jamie Heise, Mitchell L. Shiffman, J. Hammond, R. Pozza, Eric Chun, Fred Poordad, E. Godofsky, Deanine G. Halliman
Publikováno v:
Journal of Hepatology. 50:S8
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::63f29e5c54c217a1348ca09f81dffac9
https://doi.org/10.1016/s0168-8278(09)60016-7
https://doi.org/10.1016/s0168-8278(09)60016-7